Liu X - Search Results

1

The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGF1R.

Zhong D, Xiong L, Liu T, Liu X, Liu X, Chen J, Sun SY, Khuri FR, Zong Y, Zhou Q, Zhou W. Zhong D, et al. Among authors: liu x, liu t. J Biol Chem. 2009 Aug 28;284(35):23225-33. doi: 10.1074/jbc.M109.005280. Epub 2009 Jul 1. J Biol Chem. 2009. PMID: 19574224 Free PMC article.

2

p53 upregulates death receptor 4 expression through an intronic p53 binding site.

Liu X, Yue P, Khuri FR, Sun SY. Liu X, et al. Cancer Res. 2004 Aug 1;64(15):5078-83. doi: 10.1158/0008-5472.CAN-04-1195. Cancer Res. 2004. PMID: 15289308

3

c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells.

Zou W, Liu X, Yue P, Zhou Z, Sporn MB, Lotan R, Khuri FR, Sun SY. Zou W, et al. Among authors: liu x. Cancer Res. 2004 Oct 15;64(20):7570-8. doi: 10.1158/0008-5472.CAN-04-1238. Cancer Res. 2004. PMID: 15492284

4

Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.

Liu X, Yue P, Zhou Z, Khuri FR, Sun SY. Liu X, et al. J Natl Cancer Inst. 2004 Dec 1;96(23):1769-80. doi: 10.1093/jnci/djh322. J Natl Cancer Inst. 2004. PMID: 15572759

5

Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.

Jin F, Liu X, Zhou Z, Yue P, Lotan R, Khuri FR, Chung LW, Sun SY. Jin F, et al. Among authors: liu x. Cancer Res. 2005 Jul 15;65(14):6354-63. doi: 10.1158/0008-5472.CAN-04-4061. Cancer Res. 2005. PMID: 16024638

6

Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.

Liu X, Yue P, Khuri FR, Sun SY. Liu X, et al. Cancer Res. 2005 Oct 15;65(20):9169-75. doi: 10.1158/0008-5472.CAN-05-0939. Cancer Res. 2005. PMID: 16230375

7

Cellular FLICE-inhibitory protein down-regulation contributes to celecoxib-induced apoptosis in human lung cancer cells.

Liu X, Yue P, Schönthal AH, Khuri FR, Sun SY. Liu X, et al. Cancer Res. 2006 Dec 1;66(23):11115-9. doi: 10.1158/0008-5472.CAN-06-2471. Cancer Res. 2006. PMID: 17145853

8

PPARgamma ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cells.

Zou W, Liu X, Yue P, Khuri FR, Sun SY. Zou W, et al. Among authors: liu x. Cancer Biol Ther. 2007 Jan;6(1):99-106. doi: 10.4161/cbt.6.1.3555. Cancer Biol Ther. 2007. PMID: 17172826 Free article.

9

The farnesyltransferase inhibitor lonafarnib induces CCAAT/enhancer-binding protein homologous protein-dependent expression of death receptor 5, leading to induction of apoptosis in human cancer cells.

Sun SY, Liu X, Zou W, Yue P, Marcus AI, Khuri FR. Sun SY, et al. Among authors: liu x. J Biol Chem. 2007 Jun 29;282(26):18800-9. doi: 10.1074/jbc.M611438200. Epub 2007 May 9. J Biol Chem. 2007. PMID: 17493934 Free article.

10

The farnesyltransferase inhibitor R115777 up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer cells.

Qiu Y, Liu X, Zou W, Yue P, Lonial S, Khuri FR, Sun SY. Qiu Y, et al. Among authors: liu x. Cancer Res. 2007 May 15;67(10):4973-80. doi: 10.1158/0008-5472.CAN-06-4044. Cancer Res. 2007. PMID: 17510428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136,715 results

Search Page

Filters